600422 昆药集团
已收盘 11-06 15:00:00
资讯
新帖
简况
昆药集团(600422)11月3日主力资金净买入352.78万元
证券之星 · 11-04
昆药集团(600422)11月3日主力资金净买入352.78万元
昆药集团(600422)10月30日主力资金净买入431.77万元
证券之星 · 10-31
昆药集团(600422)10月30日主力资金净买入431.77万元
股市必读:昆药集团三季报 - 第三季度单季净利润同比下降102.79%
证券之星 · 10-26
股市必读:昆药集团三季报 - 第三季度单季净利润同比下降102.79%
管理层大换血难止血,昆药集团前三季度由盈转亏
东方财富网 · 10-25
管理层大换血难止血,昆药集团前三季度由盈转亏
国金证券:给予昆药集团增持评级
证券之星 · 10-25
国金证券:给予昆药集团增持评级
昆药集团(600422)9月30日股东户数5.27万户,较上期增加1.01%
证券之星 · 10-24
昆药集团(600422)9月30日股东户数5.27万户,较上期增加1.01%
昆药集团2026三季报:经营韧性增强 银发健康战略可期
东方财富网 · 10-24
昆药集团2026三季报:经营韧性增强 银发健康战略可期
图解昆药集团三季报:第三季度单季净利润同比下降102.79%
证券之星 · 10-24
图解昆药集团三季报:第三季度单季净利润同比下降102.79%
昆药集团(600422)披露2026年第三季度报告,10月23日股价上涨1.26%
证券之星 · 10-23
昆药集团(600422)披露2026年第三季度报告,10月23日股价上涨1.26%
华润医药:昆药集团前9个月净亏损约3.63亿元 同比盈转亏
同花顺 · 10-23
华润医药:昆药集团前9个月净亏损约3.63亿元 同比盈转亏
昆药集团(600422)10月22日主力资金净买入7.85万元
证券之星 · 10-23
昆药集团(600422)10月22日主力资金净买入7.85万元
昆药集团(600422)10月20日主力资金净卖出620.01万元
证券之星 · 10-21
昆药集团(600422)10月20日主力资金净卖出620.01万元
昆药集团(600422)10月14日主力资金净买入432.17万元
证券之星 · 10-15
昆药集团(600422)10月14日主力资金净买入432.17万元
股市必读:昆药集团新发布《昆药集团2026年第二次临时股东会决议公告》
证券之星 · 09-14
股市必读:昆药集团新发布《昆药集团2026年第二次临时股东会决议公告》
每周股票复盘:昆药集团(600422)2026年第二次临时股东会审议通过六项议案
证券之星 · 09-13
每周股票复盘:昆药集团(600422)2026年第二次临时股东会审议通过六项议案
每周股票复盘:昆药集团(600422)拟注册发行10亿元中期票据
证券之星 · 09-06
每周股票复盘:昆药集团(600422)拟注册发行10亿元中期票据
股市必读:昆药集团新发布《昆药集团2026年第二次临时股东会会议资料》
证券之星 · 09-03
股市必读:昆药集团新发布《昆药集团2026年第二次临时股东会会议资料》
昆药集团(600422)披露2026年第二次临时股东会会议资料,9月1日股价上涨0.58%
证券之星 · 09-01
昆药集团(600422)披露2026年第二次临时股东会会议资料,9月1日股价上涨0.58%
每周股票复盘:昆药集团(600422)将召开2026年半年度业绩说明会
证券之星 · 08-30
每周股票复盘:昆药集团(600422)将召开2026年半年度业绩说明会
昆药集团(600422)披露2026年半年度报告,8月24日股价下跌2.69%
证券之星 · 08-24
昆药集团(600422)披露2026年半年度报告,8月24日股价下跌2.69%
加载更多
公司概况
公司名称:
昆药集团股份有限公司
所属行业:
医药制造业
上市日期:
2000-12-06
主营业务:
昆药集团股份有限公司的主营业务是药物研发、生产及销售、医药流通及大健康产业。公司的主要产品是昆药络泰血塞通系列、蒿甲醚系列、华润圣火理洫王血塞通软胶囊、昆中药参苓健脾胃颗粒、舒肝颗粒、香砂平胃颗粒、贝克诺顿阿尔治玻璃酸钠注射液。公司是国家认定企业技术中心、国家高新技术创新示范企业、国家知识产权示范企业,全国医药制造业百强企业。
发行价格:
10.22
{"stockData":{"symbol":"600422","market":"SH","secType":"STK","nameCN":"昆药集团","latestPrice":8.86,"timestamp":1793948400000,"preClose":8.86,"halted":0,"volume":5903397,"delay":0,"changeRate":0,"floatShares":757000000,"shares":757000000,"eps":-0.377,"marketStatus":"已收盘","change":0,"latestTime":"11-06 15:00:00","open":8.77,"high":8.91,"low":8.73,"amount":52242100,"amplitude":0.0203,"askPrice":8.86,"askSize":89,"bidPrice":8.85,"bidSize":35,"shortable":0,"etf":0,"ttmEps":-0.377,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":5,"adr":0,"adjPreClose":8.86,"symbolType":"stock","openAndCloseTimeList":[[1793928600000,1793935800000],[1793941200000,1793948400000]],"highLimit":9.75,"lowLimit":7.97,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":756975757,"isCdr":false,"pbRate":1.38,"roa":"--","roe":"--","epsLYR":0.46,"committee":-0.636655,"marketValue":6707000000,"turnoverRate":0.0078,"status":2,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-11-09。","floatMarketCap":6707000000},"requestUrl":"/m/hq/s/600422","defaultTab":"news","newsList":[{"id":"2680701410","title":"昆药集团(600422)11月3日主力资金净买入352.78万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680701410","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680701410?lang=zh_cn&edition=full","pubTime":"2026-11-04 08:39","pubTimestamp":1793752782,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月3日收盘,昆药集团报收于8.93元,上涨2.06%,换手率1.1%,成交量8.3万手,成交额7345.34万元。近5日资金流向一览见下表:昆药集团融资融券信息显示,融资方面,当日融资买入350.18万元,融资偿还560.74万元,融资净偿还210.56万元。昆药集团主营业务:药物研发、生产及销售、医药流通及大健康产业等领域。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400010949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","600422","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679822608","title":"昆药集团(600422)10月30日主力资金净买入431.77万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679822608","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679822608?lang=zh_cn&edition=full","pubTime":"2026-10-31 08:19","pubTimestamp":1793405964,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月30日收盘,昆药集团报收于8.67元,上涨1.4%,换手率1.04%,成交量7.88万手,成交额6799.12万元。近5日资金流向一览见下表:昆药集团融资融券信息显示,融资方面,当日融资买入657.47万元,融资偿还529.72万元,融资净买入127.76万元。融券方面,融券卖出1000.0股,融券偿还2100.0股,融券余量26.19万股,融券余额227.07万元。昆药集团主营业务:药物研发、生产及销售、医药流通及大健康产业等领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100018205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0188","600422","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678113967","title":"股市必读:昆药集团三季报 - 第三季度单季净利润同比下降102.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678113967","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678113967?lang=zh_cn&edition=full","pubTime":"2026-10-26 04:35","pubTimestamp":1792960510,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘,昆药集团报收于8.81元,上涨1.26%,换手率1.52%,成交量11.51万手,成交额1.01亿元。业绩披露要点:2026年前三季度归母净利润为-3.66亿元,同比下降235.85%。公司公告汇总:董事会审议通过计提资产减值准备议案,2026年1-9月合计减少税前利润18,530.84万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600001158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678138192","title":"管理层大换血难止血,昆药集团前三季度由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2678138192","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678138192?lang=zh_cn&edition=full","pubTime":"2026-10-25 18:43","pubTimestamp":1792924996,"startTime":"0","endTime":"0","summary":"昆药集团的业绩下滑情况仍在继续。近日,昆药集团发布2026年三季报,前三季度公司实现营收27.22亿元,同比下降42.7%;净亏损为3.66亿元,而上年同期为盈利2.69亿元。其中,三季度净亏损198.19万元,虽环比大幅收窄,但仍不能扭转整体局面。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11215,202610253907261131.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11215,202610253907261131.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["BK0028","BK0239","BK0060","BK0188","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678036182","title":"国金证券:给予昆药集团增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2678036182","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678036182?lang=zh_cn&edition=full","pubTime":"2026-10-25 16:00","pubTimestamp":1792915259,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,王奔奔近期对昆药集团进行研究并发布了研究报告《Q3环比改善,基药有望助力血软未来增长》,给予昆药集团增持评级。 昆药集团 2026年10月23日,公司发布2026年三季度报告。最新盈利预测明细如下:该股最近90天内共有2家机构给出评级,买入评级1家,增持评级1家;过去90天内机构目标均价为13.82。本文数据来源于国金证券股份有限公司,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102500002933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677990425","title":"昆药集团(600422)9月30日股东户数5.27万户,较上期增加1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677990425","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677990425?lang=zh_cn&edition=full","pubTime":"2026-10-24 17:07","pubTimestamp":1792832850,"startTime":"0","endTime":"0","summary":"证券之星消息,近日昆药集团披露,截至2026年9月30日公司股东户数为5.27万户,较6月30日增加527.0户,增幅为1.01%。在中药行业个股中,昆药集团股东户数低于行业平均水平,截至9月30日,中药行业平均股东户数为5.27万户。从股价来看,2026年6月30日至2026年9月30日,昆药集团区间涨幅为5.9%,在此期间股东户数增加527.0户,增幅为1.01%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102400013905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0028","600422","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677291905","title":"昆药集团2026三季报:经营韧性增强 银发健康战略可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2677291905","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677291905?lang=zh_cn&edition=full","pubTime":"2026-10-24 09:05","pubTimestamp":1792803900,"startTime":"0","endTime":"0","summary":"10月23日晚间,昆药集团股份有限公司(以下简称“昆药集团”)发布2026年第三季度报告。数据显示,前三季度公司实现营业收入27.22亿元、归母净利润亏损3.66亿元;第三季度实现营业收入10.79亿元、归母净利润亏损0.02亿元。在上半年整体承压之后,公司第三季度经营边际改善信号初显,归母净利润、扣非后归母净利润环比均实现减亏,经营韧性增强。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11215,202610243907058965.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11215,202610243907058965.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["BK0188","BK0060","BK0239","BK0028","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677979791","title":"图解昆药集团三季报:第三季度单季净利润同比下降102.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677979791","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677979791?lang=zh_cn&edition=full","pubTime":"2026-10-24 01:04","pubTimestamp":1792775055,"startTime":"0","endTime":"0","summary":"证券之星消息,昆药集团2026年三季报显示,前三季度公司主营收入27.22亿元,同比下降42.7%;归母净利润-3.66亿元,同比下降235.85%;扣非净利润-4.36亿元,同比下降472.62%;其中2026年第三季度,公司单季度主营收入10.79亿元,同比下降22.9%;单季度归母净利润-198.19万元,同比下降102.79%;单季度扣非净利润-4615.96万元,同比下降35.88%;负债率38.77%,投资收益498.84万元,财务费用2785.56万元,毛利率21.61%。归属于上市公司股东的净利润变动幅度为-235.85%,原因:营业收入同比下降,减值准备计提增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102400002123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677973103","title":"昆药集团(600422)披露2026年第三季度报告,10月23日股价上涨1.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677973103","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677973103?lang=zh_cn&edition=full","pubTime":"2026-10-23 22:39","pubTimestamp":1792766344,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘,昆药集团报收于8.81元,较前一交易日上涨1.26%,最新总市值为66.69亿元。近日,昆药集团披露《2026年第三季度报告》。公告显示,本报告期营业收入为1,079,333,525.41元,同比下降22.90%;年初至报告期末营业收入为2,722,378,839.14元,同比下降42.70%。本报告期利润总额为-17,518,798.08元,同比下降122.04%;年初至报告期末利润总额为-413,195,629.26元,同比下降209.19%。归属于上市公司股东的净利润本报告期为-1,981,854.15元,同比下降102.79%;年初至报告期末为-365,929,467.21元,同比下降235.85%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300045932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0188","600422","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677925784","title":"华润医药:昆药集团前9个月净亏损约3.63亿元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2677925784","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677925784?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:40","pubTimestamp":1792752000,"startTime":"0","endTime":"0","summary":"华润医药(03320)公布昆药集团2026年前9个月业绩,营业总收入约27.22亿元,同比减少42.7%;净亏损约3.63亿元,同比盈转亏。 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20261023/c681037400.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20261023/c681037400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0188","BK0239","BK0028","600422","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677150918","title":"昆药集团(600422)10月22日主力资金净买入7.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677150918","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677150918?lang=zh_cn&edition=full","pubTime":"2026-10-23 08:19","pubTimestamp":1792714782,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月22日收盘,昆药集团报收于8.7元,上涨0.0%,换手率1.13%,成交量8.53万手,成交额7379.51万元。近5日资金流向一览见下表:昆药集团融资融券信息显示,融资方面,当日融资买入306.32万元,融资偿还562.61万元,融资净偿还256.29万元。昆药集团主营业务:药物研发、生产及销售、医药流通及大健康产业等领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300007443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","600422","BK0028","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677648888","title":"昆药集团(600422)10月20日主力资金净卖出620.01万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677648888","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677648888?lang=zh_cn&edition=full","pubTime":"2026-10-21 08:33","pubTimestamp":1792542819,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月20日收盘,昆药集团报收于8.66元,下跌1.81%,换手率2.67%,成交量20.2万手,成交额1.79亿元。近5日资金流向一览见下表:昆药集团融资融券信息显示,融资方面,当日融资买入1480.39万元,融资偿还937.01万元,融资净买入543.38万元。昆药集团主营业务:药物研发、生产及销售、医药流通及大健康产业等领域。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100007312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","600422","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675756353","title":"昆药集团(600422)10月14日主力资金净买入432.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675756353","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675756353?lang=zh_cn&edition=full","pubTime":"2026-10-15 08:18","pubTimestamp":1792023511,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月14日收盘,昆药集团报收于8.49元,上涨1.8%,换手率0.74%,成交量5.63万手,成交额4755.94万元。近5日资金流向一览见下表:昆药集团融资融券信息显示,融资方面,当日融资买入647.1万元,融资偿还270.07万元,融资净买入377.03万元。融券方面,融券卖出7600.0股,融券偿还1.39万股,融券余量33.62万股,融券余额285.43万元。昆药集团主营业务:药物研发、生产及销售、医药流通及大健康产业等领域。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500006874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0060","BK0239","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667638202","title":"股市必读:昆药集团新发布《昆药集团2026年第二次临时股东会决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667638202","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667638202?lang=zh_cn&edition=full","pubTime":"2026-09-14 04:09","pubTimestamp":1789330151,"startTime":"0","endTime":"0","summary":"公司公告汇总:昆药集团于9月11日召开2026年第二次临时股东会,审议通过六项议案,包括聘请2026年度审计机构、修订《公司章程》及《募集资金管理制度》、追加日常关联交易额度、开展应收账款保理业务、利用闲置自有资金进行投资理财。公司公告汇总昆药集团2026年第二次临时股东会决议公告昆药集团股份有限公司于2026年9月11日召开2026年第二次临时股东会,出席会议的股东所持表决权股份占公司有表决权股份总数的39.4327%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422","BK0060","BK0239","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667002235","title":"每周股票复盘:昆药集团(600422)2026年第二次临时股东会审议通过六项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2667002235","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667002235?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:49","pubTimestamp":1789242550,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总:昆药集团2026年第二次临时股东会审议通过关于聘请2026年度审计机构等六项议案。公司公告汇总昆药集团股份有限公司于2026年9月11日召开2026年第二次临时股东会,会议由董事长喻翔主持,出席股东所持表决权股份占公司有表决权股份总数的39.4327%。昆药集团章程明确公司注册资本为756,975,757元,股东会为公司权力机构。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0239","BK0060","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665366892","title":"每周股票复盘:昆药集团(600422)拟注册发行10亿元中期票据","url":"https://stock-news.laohu8.com/highlight/detail?id=2665366892","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665366892?lang=zh_cn&edition=full","pubTime":"2026-09-06 03:03","pubTimestamp":1788634992,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,昆药集团报收于8.49元,较上周的8.71元下跌2.53%。本周,昆药集团8月31日盘中最高价报8.71元。昆药集团当前最新总市值64.27亿元,在中药板块市值排名31/66,在两市A股市值排名2618/5214。本周关注点公司公告汇总:昆药集团获准注册发行10亿元中期票据,额度两年内有效。公司公告汇总:昆药集团拟使用不超过20亿元闲置自有资金进行理财投资。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0239","600422","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664845135","title":"股市必读:昆药集团新发布《昆药集团2026年第二次临时股东会会议资料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664845135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664845135?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:12","pubTimestamp":1788372734,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘,昆药集团报收于8.52元,下跌1.16%,换手率0.73%,成交量5.56万手,成交额4738.39万元。公司公告汇总:昆药集团获交易商协会10亿元中期票据注册通知,有效期两年,由兴业银行、招商银行和中国银行联席主承销。公司公告汇总:公司召开2026年第二次临时股东会,审议通过包括修订《公司章程》中法定代表人由总裁调整为董事长、追加日常关联交易额度5.6亿元、开展不超过2亿元应收账款保理业务等多项议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300001984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600422","BK0060","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664505948","title":"昆药集团(600422)披露2026年第二次临时股东会会议资料,9月1日股价上涨0.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664505948","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664505948?lang=zh_cn&edition=full","pubTime":"2026-09-01 23:13","pubTimestamp":1788275592,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘,昆药集团报收于8.62元,较前一交易日上涨0.58%,最新总市值为65.25亿元。该股当日开盘8.57元,最高8.65元,最低8.53元,成交额达4191.88万元,换手率为0.64%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0028","600422","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663804398","title":"每周股票复盘:昆药集团(600422)将召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2663804398","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663804398?lang=zh_cn&edition=full","pubTime":"2026-08-30 07:36","pubTimestamp":1788046574,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,昆药集团报收于8.71元,较上周的8.54元上涨1.99%。本周,昆药集团8月26日盘中最高价报8.77元。本周关注点来自公司公告汇总:昆药集团将于2026年9月4日召开2026年半年度业绩说明会。公司公告汇总昆药集团关于召开2026年半年度业绩说明会的公告昆药集团股份有限公司将于2026年9月4日15:00-16:00通过全景路演平台以网络文字互动方式召开2026年半年度业绩说明会,介绍公司2026年半年度经营成果、财务状况,并回答投资者提问。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000003941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600422","BK0188","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661220471","title":"昆药集团(600422)披露2026年半年度报告,8月24日股价下跌2.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661220471","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661220471?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:13","pubTimestamp":1787566392,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘,昆药集团报收于8.31元,较前一交易日下跌2.69%,最新总市值为62.9亿元。该股当日开盘8.48元,最高8.5元,最低8.28元,成交额达7045.24万元,换手率为1.11%。昆药集团于近日披露《2026年半年度报告》。总资产为10,980,313,179.26元,较上年度末减少6.74%;归属于上市公司股东的净资产为4,864,074,777.36元,较上年度末减少9.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400026026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","600422","BK0239","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794121765440,"stockEarnings":[{"period":"1week","weight":0.0219},{"period":"1month","weight":0.0925},{"period":"3month","weight":0.0045},{"period":"6month","weight":-0.0438},{"period":"1year","weight":-0.3277},{"period":"ytd","weight":-0.2806}],"compareEarnings":[{"period":"1week","weight":0.0139},{"period":"1month","weight":-0.0502},{"period":"3month","weight":-0.0738},{"period":"6month","weight":-0.127},{"period":"1year","weight":-0.0895},{"period":"ytd","weight":-0.0805}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"昆药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"52709人(较上一季度增加1.01%)","perCapita":"14361股","listingDate":"2000-12-06","address":"云南省昆明市五华区国家高新技术产业开发区科医路166号","registeredCapital":"75697万元","survey":" 昆药集团股份有限公司的主营业务是药物研发、生产及销售、医药流通及大健康产业。公司的主要产品是昆药络泰血塞通系列、蒿甲醚系列、华润圣火理洫王血塞通软胶囊、昆中药参苓健脾胃颗粒、舒肝颗粒、香砂平胃颗粒、贝克诺顿阿尔治玻璃酸钠注射液。公司是国家认定企业技术中心、国家高新技术创新示范企业、国家知识产权示范企业,全国医药制造业百强企业。","listedPrice":10.22},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昆药集团(600422)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昆药集团(600422)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昆药集团,600422,昆药集团股票,昆药集团股票老虎,昆药集团股票老虎国际,昆药集团行情,昆药集团股票行情,昆药集团股价,昆药集团股市,昆药集团股票价格,昆药集团股票交易,昆药集团股票购买,昆药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昆药集团(600422)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昆药集团(600422)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}